1. Home
  2. Insider Trading Stock Activity
  3. Reynoso Jamie L.
Reynoso Jamie L.

Reynoso Jamie L.

CEO, Medicare Advantage of CLOV

Stock Insider Trading Activity of Reynoso Jamie L.

Reynoso Jamie L.

CEO, Medicare Advantage

Sell
CLOV Jan 7, 2026

Avg Cost/Share

$2.53

Shares

2,102

Total Value

$5,318.06

Owned After

2,757,029

SEC Form 4

Reynoso Jamie L.

CEO, Medicare Advantage

Sell
CLOV Dec 18, 2025

Avg Cost/Share

$2.61

Shares

4,913

Total Value

$12,822.93

Owned After

2,757,029

SEC Form 4

Reynoso Jamie L.

CEO, Medicare Advantage

Sell
CLOV Nov 4, 2025

Avg Cost/Share

$3.58

Shares

30,385

Total Value

$108,778.30

Owned After

2,757,029

SEC Form 4

Reynoso Jamie L.

CEO, Medicare Advantage

Sell
CLOV Oct 17, 2025

Avg Cost/Share

$2.69

Shares

16,514

Total Value

$44,422.66

Owned After

2,757,029

SEC Form 4

Reynoso Jamie L.

CEO, Medicare Advantage

Sell
CLOV Oct 7, 2025

Avg Cost/Share

$2.65

Shares

2,012

Total Value

$5,331.80

Owned After

2,757,029

SEC Form 4

Reynoso Jamie L.

CEO, Medicare Advantage

Sell
CLOV Sep 17, 2025

Avg Cost/Share

$3.09

Shares

4,914

Total Value

$15,184.26

Owned After

2,757,029

SEC Form 4

Reynoso Jamie L.

CEO, Medicare Advantage

Sell
CLOV Jun 17, 2025

Avg Cost/Share

$2.86

Shares

20,450

Total Value

$58,487.00

Owned After

2,757,029

SEC Form 4

Share on Social Networks: